Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination

Immunology. 2014 Oct;143(2):300-9. doi: 10.1111/imm.12310.

Abstract

The ectodomain of matrix protein 2 (M2e) of influenza virus is considered a rational target for a universal influenza A vaccine. To better understand M2e immune-mediated protection, Fc receptor common γ chain deficient (FcRγ(-/-) ) and wild-type mice were immunized with a tandem repeat of M2e presented on virus-like particles (M2e5x VLP). Levels of M2e-specific antibodies that were induced in FcRγ(-/-) mice after immunization with M2e5x VLP were similar to those in wild-type mice. In addition, M2e antibodies induced in FcRγ(-/-) mice were found to be equally protective as those induced in wild-type mice. However, M2e5x VLP-immunized FcRγ(-/-) mice were not well protected, as shown by severe weight loss, higher lung viral titres and interleukin-6 inflammatory cytokine production upon influenza virus challenge compared with M2e5x VLP-immunized wild-type mice. Importantly, FcRγ(-/-) mice that were immunized with inactivated influenza virus induced haemagglutination inhibition activity and were well protected without a significant weight loss. Interestingly, interferon-γ-producing CD4 T and CD8 T cells were found to be prevalent in lungs from M2e5x VLP-immunized FcRγ(-/-) mice, which appeared to be correlated with a faster recovery after infection. These results indicate that Fc receptors play a primary role in conferring M2e-specific antibody-mediated protection whereas T cells may contribute to the recovery at later stages of infection.

Keywords: Fc receptor; T cells; influenza virus; matrix protein 2 ectodomain antibodies; matrix protein 2 ectodomain virus-like particles.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • Cells, Cultured
  • Disease Models, Animal
  • Female
  • Hemagglutination
  • Inflammation Mediators / blood
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / immunology*
  • Interferon-gamma / metabolism
  • Interleukin-6 / blood
  • Lung / immunology*
  • Lung / virology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Orthomyxoviridae Infections / blood
  • Orthomyxoviridae Infections / genetics
  • Orthomyxoviridae Infections / immunology
  • Orthomyxoviridae Infections / prevention & control*
  • Orthomyxoviridae Infections / virology
  • Receptors, IgG / deficiency
  • Receptors, IgG / genetics
  • Receptors, IgG / metabolism*
  • Remission Induction
  • Time Factors
  • Vaccination*
  • Viral Load
  • Viral Matrix Proteins / administration & dosage
  • Viral Matrix Proteins / immunology*
  • Weight Loss

Substances

  • Antibodies, Viral
  • Inflammation Mediators
  • Influenza Vaccines
  • Interleukin-6
  • M2 protein, Influenza A virus
  • Receptors, IgG
  • Viral Matrix Proteins
  • interleukin-6, mouse
  • Interferon-gamma